May Daher, MD is a physician scientist, Assistant Professor in the Stem Cell Transplant and Cellular Therapy Department at MD Anderson Cancer Center. May is also the Associate Director of Translational Research in the Department of Stem Cell Transplantation and the Associate Director of the Cell Engineering Group in the GMP facility. May received her M.D. degree at the American University of Beirut in Lebanon with Distinction, after which she completed an Internal Medicine residency program at Vanderbilt University Medical Center and a fellowship training program in Hematology and Medical Oncology at MD Anderson Cancer Center with a focus on cancer immunology, cellular immune therapy and hematopoietic transplantation.
She also completed a postdoctoral fellowship in the translational laboratory of Dr. Katy Rezvani where she was instrumental in advancing the CAR-NK cell therapy platform. Her laboratory research focuses on developing novel cellular engineering strategies and incorporating gene editing techniques to enhance the metabolic fitness and potency of cellular therapy products, surmount the immunosuppressive tumor microenvironment and circumvent immune evasion mechanisms developed by tumors. As a physician, Dr. Daher is working on translating these novel therapies to the clinic to treat patients with relapsed refractory malignancies.